Cryo-Cell IntlCCEL
13F holders, Q2 2026 (June 30)12holders +1
2new positions
1sold out
$3.19avg. 13F price*
At the end of Q2 2026, 12 institutions reported holding Cryo-Cell Intl Inc. (CCEL) in their 13F filings, up 1 from Q1 2026. 2 opened new positions and 1 sold out. The largest holders were SFI Advisors, LLC ($527K), Vanguard Capital Management LLC ($526K) and MassMutual Private Wealth & Trust, FSB ($354K).
- Company
- Cryo-Cell Intl Inc.
- CUSIP
- 228895108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $64K |
| Exits | 1 | $355 |
All 13F filers, Q1 2026 → Q2 2026: 30,173 shares bought and 7,743 shares sold, net +22,430 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| SFI Advisors, LLC | 0.45% | No change | 165,300 | $527K |
| Vanguard Capital Management LLC | 0.00% | Add +2.1% | 164,976 | $526K |
| MassMutual Private Wealth & Trust, FSB | 0.01% | No change | 111,035 | $354K |
| Geode Capital Management, LLC | 0.00% | Add +6.1% | 46,273 | $148K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 23,346 | $74K |
| FMR LLC | 0.00% | New | 20,000 | $64K |
| Susquehanna International Group, LLP | 0.00% | Add +40.4% | 14,064 | $45K |
| BlackRock, Inc. | 0.00% | Reduce -52.1% | 6,696 | $21K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,500 | $8K |
| Morgan Stanley | 0.00% | Add +0.7% | 605 | $2K |
| UBS Group AG | 0.00% | Reduce -53.0% | 316 | $1K |
| Barclays PLC | 0.00% | New | 14 | $45 |
"% of holder's portfolio" is CCEL's weight in each manager's 13F, not the share of Cryo-Cell Intl Inc. the manager owns.